It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 | Mumbai, Maharashtra, India | ActiveHoneybell Pharma Private Limited, a active private limited company, was established on 12 November 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999MH2018PTC316948. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
Its leadership includes Ankit Kumar Lalit Kumar Jain (Additional Director), Bhavesh Prakash Jain (Director), Sanjay Sampatraj Parekh (Additional Director). Past directors included Niravkumar Lalitkumar Jain, Nayan Pravin Thakkar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 82/90,Ground Floor,Anandbhavan,Kalbadevi Shamaldas Gandhi Marg, Lohar Chawl,, Mumbai, Maharashtra, 400002.
U74999MH2018PTC316948
316948
12 November 2018
₹1.00 M
₹0.30 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Honeybell Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankit Kumar Lalit Kumar Jain | Additional Director | 29 Sep 2020 | Current |
| Bhavesh Prakash Jain | Director | 12 Nov 2018 | Current |
| Sanjay Sampatraj Parekh | Additional Director | 01 Apr 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2020 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Honeybell Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1864.44% increase. The company also saw a substantial improvement in profitability, with a 326.81% increase in profit. The company's net worth Soared by an impressive increase of 3830.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Honeybell Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Honeybell Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Honeybell Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Honeybell Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Honeybell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Honeybell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Ankit Kumar Lalit Kumar Jain was appointed as a Additional Director was appointed as a Additional Director on 29 Sep 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Sanjay Sampatraj Parekh was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
Progress on Bhavesh Prakash Jain was appointed as a Director was appointed as a Director on 12 Nov 2018 & has been associated with this company since 7 years 1 month . was documented.
Progress on Honeybell Pharma Private Limited was registered on 12 Nov 2018 with Roc Mumbai & aged 7 years 1 month as per MCA records. was documented.
The CIN of Honeybell Pharma Private Limited is U74999MH2018PTC316948.
Honeybell Pharma Private Limited is headquartered at 82/90,Ground Floor,Anandbhavan,Kalbadevi Shamaldas Gandhi Marg, Lohar Chawl,, Mumbai, Maharashtra, 400002.
Honeybell Pharma Private Limited was incorporated on 12 November 2018.
The current directors of Honeybell Pharma Private Limited are
The primary industry of Honeybell Pharma Private Limited is Pharma.
Honeybell Pharma Private Limited is unlisted.
The authorized capital of Honeybell Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX